United States· US:62856-720_980cbc09-76e3-4b8f-a8c4-d8adf6743b55
Lenvima
A lenvatinib product containing lenvatinib, registered in United States by Eisai Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lenvatinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EX08 (lenvatinib), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Lenvatinib · ATC L01EX08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lenvatinib costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lenvatinib · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$297.39
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LENVATINIB
- Manufacturer
- Eisai Inc.
- Country
- United States (US)
- ATC code
- L01EX08
- ATC class
- Lenvatinib
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 26, 2026
Packs & prices · 2
- ndc1162856-720-30
- ndc1162856720306 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-720-30) / 10 CAPSULE in 1 BLISTER PACK (62856-720-05)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for lenvatinib.
Graded by severity as the source publishes them — 81 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lenvatinib · interactions on record
315 records
- 81 severe
- 230 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lenvatinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKISPLYXEisai GmbH, Frankfurt am Main
- NetherlandsKisplyx 10 mg, harde capsuleEisai GmbH
- FinlandIxedafinSTADA Arzneimittel AG
- SwedenKisplyx 10 mg Kapsel, hårdEisai GmbH
- IrelandKisplyx 10 mg hard capsulesEisai GmbH
- SpainKISPLYX 10 MG CAPSULAS DURASEisai Gmbh
- BelgiumIxedafin 10 mgStada Arzneimittel
- NorwayKisplyxEisai GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lenvatinib Accord, Lenvatinib Rcc Sandoz
- Belgium · Ixedafin, Lenvatinib Accord
- Bulgaria · Ленватиниб Виатрис
- Cyprus · Lenvatinib Remedica
- Czechia · Lenvatinib Accord, Lenvatinib Sandoz
- Germany · Lenvatinib Accord, Lenvatinib Hexal
- Denmark · Lenvatinib Accord, Lenvatinib Sandoz
- Estonia · Lenvatinib Remedica, Lenvatinib Sandoz
- Spain · Lenvatinib Accord, Lenvatinib Sandoz
- Finland · Ixedafin, Lenvatinib
- France · Lenvatinib Accord, Lenvatinib Biogaran
- United Kingdom (Northern Ireland) · Lenvatinib, Lenvatinib Thornton & Ross
- Greece · Kynvalib, Lenvatinib Elpen
- Croatia · Lenvatinib Remedica
- Hungary · Lenvatinib Stada
- Ireland · Lenvatinib Accord, Lenvatinib Stada
- Iceland · Kisplyx, Lenvima
- Italy · Lenvatinib Accord, Lenvatinib Sandoz
- Liechtenstein · Kisplyx, Lenvima
- Lithuania · Lenvatinib Sandoz, Lenvatinib Stada
- Luxembourg · Ixedafin, Lenvatinib Olpha
- Latvia · Lenvatinib Sandoz, Lenvatinib Stada
- Malta · Lenvatinib Remedica, Lenvatinib Stada
- Netherlands · Lenvatinib 1a Pharma, Lenvatinib Accord
- Norway · Kisplyx, Lenvatinib Accord
- Portugal · Lenvatinib Accord, Lenvatinib Sandoz
- Sweden · Lenvatinib Accord, Lenvatinib Avansor
- Slovenia · 10 Mg, Lenvatinib Sandoz
- Slovakia · Lenvatinib Pharmevid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af03a575-dcec-4181-b90d-76b7575865c1 GET /v1/drugs/af03a575-dcec-4181-b90d-76b7575865c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "LENVATINIB",
"productndc": "62856-720",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA206947",
"marketing_category": "NDA"
}See everything about lenvatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.